CD274 and hepatocellular carcinoma: The positive expression rate of PD-L1 in HCC tumor cells was less than 10%, and no significant correlation was found between the positive expression of PD-L1 and the efficacy of immunotherapy in HCC patients in KEYNOTE-224 and CheckMate 040 studies (45, 46).